Blogs

In the pharmaceutical solid dose manufacturing process, the journey from raw powder to finished tablet involves several distinct steps.

Every tablet that exits a rotary tablet press machine carries surface dust. This dust is an unavoidable consequence of the compression process: fine powder particles that were not fully compacted into the tablet body adhere to the tablet surface during compression, and the mechanical action of the punches and dies generates additional powder fragments as tablets are ejected and collected.

South Africa occupies a unique position in African pharmaceutical manufacturing. It is the continent's largest pharmaceutical market by value, accounting for approximately 34 percent of total African pharmaceutical market revenue.

As pharmaceutical treatment protocols become more sophisticated, the demand for fixed-dose combination products has grown significantly.

The United Arab Emirates has historically been a major pharmaceutical importer and distributor, serving as the commercial hub through which medicines flow to the broader Middle East, Africa, and South Asian markets.

Kenya has developed the most significant pharmaceutical manufacturing industry in East Africa over the past three decades.

Before powder becomes a tablet, it almost always goes through a granulation step. Most pharmaceutical APIs and excipient blends in their raw powder form are not suitable for direct compression on a rotary tablet press machine.

The global nutraceutical market has experienced sustained double-digit growth over the past decade, and tablet form remains the dominant delivery format for vitamins, minerals, herbal supplements, and functional nutrition products.

IQ OQ PQ validation, standing for Installation Qualification, Operational Qualification, and Performance Qualification, is the internationally recognised framework for demonstrating that a tablet press machine is installed correctly, operates within specification, and consistently produces tablets meeting quality requirements.

Tablet compression machine problems are a significant source of production losses in pharmaceutical manufacturing, including rejected batches, unplanned downtime, wasted active pharmaceutical ingredient, and potential regulatory documentation failures.

India is the world's leading supplier of pharmaceutical equipment including tablet press machines, with manufacturers ranging from established names with decades of export experience to newer suppliers offering lower prices with limited support capability.

Bangladesh is one of the fastest-growing pharmaceutical export economies in the world, exporting to over 160 countries, but the end of its Least Developed Country status is removing the duty-free access that made Bangladeshi generics highly competitive and forcing manufacturers to upgrade to FDA-compliant automatic production equipment.

Nigeria currently imports approximately 70 percent of its pharmaceutical requirements and the government has set a target of achieving 70 percent local production by 2030, creating the largest single wave of pharmaceutical manufacturing investment in sub-Saharan Africa.

Saudi Arabia is the fastest-growing pharmaceutical manufacturing market in the Middle East, driven by Vision 2030 investment of USD 65 billion in healthcare and a government mandate to localise drug production and reduce pharmaceutical imports.

B tooling and D tooling are the two primary international standards for tablet press punches and dies, and choosing the wrong type for your machine or product can result in compatibility failures, tablet defects, and regulatory complications.